Celgene Reports Fourth Quarter and Full Year 2015 Operating and Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to Celgene Reports Fourth Quarter and Full Year 2015 Operating and Financial Results

Jefferies Cuts Price Target on Celgene (CELG) as FX Weighs on Near-Term

January 29, 2016 9:07 AM EST

Jefferies maintained a Buy rating on Celgene (NASDAQ: CELG), and cut the price target to $146.00 (from $149.00), following the company's 4Q earnings report. FX volatility appears to be weighing a bit on near-term performance prospects. CELG noted that the ~$700-800M negative top-line impact... More

Celgene (CELG) Misses Q4 EPS by 4c

January 28, 2016 7:32 AM EST

Celgene (NASDAQ: CELG) reported Q4 EPS of $1.18, $0.04 worse than the analyst estimate of $1.22. Revenue for the quarter came in at $2.54 billion versus the consensus estimate of $2.54 billion.

GUIDANCE:

Celgene sees Q1 2016 EPS of $1.27-$1.30, versus the consensus of... More